↓ Skip to main content

PLOS

Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy

Overview of attention for article published in PLOS ONE, December 2012
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Readers on

mendeley
34 Mendeley
Title
Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
Published in
PLOS ONE, December 2012
DOI 10.1371/journal.pone.0050035
Pubmed ID
Authors

Jianxiong Wu, Jun Du, Liguo Liu, Qian Li, Weiqi Rong, Liming Wang, Ying Wang, Mengya Zang, Zhiyuan Wu, Yawei Zhang, Chunfeng Qu

Abstract

Primary hepatocellular carcinoma (HCC) is usually presented in inflamed fibrotic/cirrhotic liver with extensive lymphocyte infiltration. We examined the associations between the HCC early recurrence and alterations in serum levels of inflammatory cytokines.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 3%
Canada 1 3%
Unknown 32 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 26%
Other 6 18%
Student > Master 4 12%
Student > Bachelor 3 9%
Researcher 3 9%
Other 6 18%
Unknown 3 9%
Readers by discipline Count As %
Medicine and Dentistry 11 32%
Agricultural and Biological Sciences 5 15%
Immunology and Microbiology 4 12%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 2 6%
Other 5 15%
Unknown 5 15%